 Kathleen Sebelius, Scott Gottlieb, Reps. Elissa Slotkin and Buddy Carter headline The Hill's COVID-19 & A Responsive Rx Supply Chain The global pandemic has led to an unprecedented demand for medicines. Since the early days of the crisis, hospitals have used a variety of treatments - some experimental - to target the virus. And physicians have encouraged patients to refill their prescriptions for a longer period. In a pandemic, both the healthcare system and patients have changed behaviors. As a consequence, concerns and fears have arisen surrounding drug availability and shortages. What are stakeholders doing to ensure that disruptions do not occur, especially as we head into flu season and colder weather? And what plans are being put in place for the distribution of a coronavirus vaccine once available? Today at 1:00PM Eastern, The Hill sits down with healthcare stakeholders for a conversation about ensuring resilience in the pharmaceutical supply chain whether in the face of the current pandemic or future health crises. Featuring: Kathleen Sebelius, Former Secretary of Health and Human Services Scott Gottlieb, MD, Former FDA Commissioner Rep. Buddy Carter (R-GA) Rep. Elissa Slotkin (D-MI) Heather Zenk, AmerisourceBergen Corporation Joshua Sharfstein, Johns Hopkins Bloomberg School of Public Health Elena Rios, National Hispanic Medical Association Watch Today!
1:00 PM Eastern/10:00 AM Pacific
Tuesday, October 27th Questions for our speakers? Join the conversation using #TheHillRxSupplyChain. | 
No comments:
Post a Comment